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Abstract
The Communicable Diseases Network Australia
guidelines provide information for early clinical
and public health management of meningococcal
disease, including community outbreaks. While
community outbreaks of meningococcal serogroup
C infections have been reported, community outbreaks of meningococcal serogroup B infections
have not been declared in Australia. Three cases
of meningococcal serogroup B disease occurred
in 2 adjacent suburbs in western Sydney in Spring
2008. Although the temporal and geographic
proximity of these cases fulfilled the criteria for
a community outbreak, difficulties in establishing
an epidemiological or serosubgroup link, and
arbitrary definition of the term ‘community’ provide challenges for identifying such outbreaks. In
addition, the declaration of a community outbreak
of meningococcal B infection does not provide
guidance for the public health response because
a vaccine is not available and community-wide
prophylaxis is not recommended. Commun Dis
Intell 2009;33:221–224.
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Introduction
The Communicable Diseases Network Australia
(CDNA) guidelines1 define a community outbreak of meningococcal disease as ‘three or more
confirmed cases with onset in a 3 month interval,
where the available microbiological characterisation of the organisms is the same, and incidence is
at least 10 per 100,000 total community population
in a 3 month interval’ (p 52). Community outbreaks
tend to be more difficult to define and manage than
organisation-based outbreaks for several reasons.
Firstly, it is difficult to distinguish a community
outbreak from normal fluctuations in disease incidence because of the arbitrary nature of choosing
geographic boundaries for defining the population
at risk in metropolitan areas. Secondly, if there is
no obvious epidemiological link between cases, the
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public health response may include conducting
expensive and logistically challenging mass vaccination clinics. The CDNA guidelines explicitly state
that ‘Community-wide clearance antibiotics should
not be used’ (p 57). Finally, other consequent public
health activities such as active surveillance and
mass media alerts can result in stigmatisation of the
defined community.
The average annual notification rate of meningococcal
infections (all serogroups) has decreased similarly in
both New South Wales and Australia from approximately 3.5 to 1.5 per 100,000 population since the
meningococcal serogroup C (MSC) vaccine was added
to the National Immunisation Program in 2003. A
number of organisation-based outbreaks of MSC were
reported in Australia prior to or just after the vaccine
was introduced. These were in secondary schools,2,3,4
a university college,5 and clustered within a family.6
Two MSC community clusters have been described
previously in western Sydney, the first a community
outbreak in Campbelltown7 and the second associated
with a nightclub in Penrith.8
Since the introduction of the MSC vaccine,
meningococcal serogroup B (MSB) has been most
commonly identified in laboratory confirmed cases
both in New South Wales and nationally, accounting for 68% and 80% of notifications respectively in
2006.9 However, MSB only causes sporadic cases in
Australia.10 Isaac-Toua and colleagues reported a
number of community-based cases of MSB within a
3 month period in the Australian Capital Territory
in early 2004.11 However, they did not have sufficient numbers to reach the criterion of 10 cases per
100,000 population and therefore did not declare a
community outbreak of MSB.

Methods and results
Description of the outbreak and public health
investigation

Three cases of MSB disease occurred in 2 adjacent
suburbs in the Penrith Local Government Area
(LGA) in western Sydney with a combined population of approximately 28,000.12 This equated to

221

Short report

10.7 cases per 100,000 population across the 2 suburbs
within 1 month, which met the CDNA definition of
a community outbreak.1 A summary of critical events
in the outbreak is shown in the Figure.

hours later. A lumbar puncture was carried out and
gram negative diplococci were identified in the
cerebrospinal fluid.
All cases fully recovered after a period of seven to
10 days in hospital with treatment in accordance
with the CDNA guidelines.

Case 1 (female, aged 9) had complained of a
sore stomach and headache during the days
prior to presenting to a general practitioner on
26 September 2008. By this time further symptoms
had developed (rash, numb legs) which suggested
meningococcal disease. The patient was immediately treated with intramuscular benzyl penicillin
and taken to hospital. Although a blood culture was
attempted, there was no bacterial growth.

Routine case histories were taken at the time of
notification to the public health unit using the
NSW Health Department Meningococcal Disease
questionnaire,13 noting in particular any special functions or extra-curricular school activities. Contacts of
cases were identified and managed in accordance
with Australian guidelines, including the provision
of information and clearance antibiotics.

Case 2 (female, aged 2), from the same suburb as
case 1, became ill on 28 September 2008 and progressively worsened over the next few days until she was
admitted to hospital with suspected gastroenteritis on
29 September 2008. The diagnosis was changed to
meningococcal infection the following day as classic
symptoms (stiff neck and photophobia) became apparent. A blood culture was requested and gram negative
diplococci were identified.

All cases were fully vaccinated for age against
MSC, confirmed by the Australian Childhood
Immunisation Register records for cases 1 and 2,
and school program vaccination records for case 3.
Case 1 had only attended school on 1 day in the
week before symptom onset, due to absence with
earlier symptoms of stomach ache and headache.
Case 2 was too young to attend school and was not
in child care. Case 3 attended school in the week
prior to symptom onset, but not the same school as
case 1.

Case 3 (female, aged 13), from a suburb adjacent
to cases 1 and 2, saw a general practitioner on
18 October 2008 with fever and vomiting and was
diagnosed with viral gastroenteritis. However the
patient deteriorated rapidly and was admitted to
the Intensive Care Unit of a local hospital a few

Polymerase chain reaction testing of blood (n=1) or
cerebrospinal fluid (n=2) samples from each case
confirmed Neisseria meningitis serogroup B in all

Figure: Time line of investigation into meningococcal serogroup B cluster in western Sydney

Follow-up
investigation
Under 18 dance party
attended by case 3 and
sibling of case 1

31-Oct-08

30-Oct-08

29-Oct-08

28-Oct-08

27-Oct-08

26-Oct-08

25-Oct-08

24-Oct-08

23-Oct-08

22-Oct-08

21-Oct-08

20-Oct-08

19-Oct-08

18-Oct-08

17-Oct-08

16-Oct-08

15-Oct-08

14-Oct-08

13-Oct-08

12-Oct-08

11-Oct-08

9-Oct-08

10-Oct-08

8-Oct-08

7-Oct-08

6-Oct-08

5-Oct-08

4-Oct-08

3-Oct-08

Case 3
admitted

2-Oct-08

1-Oct-08

30-Sep-08

28-Sep-08

Case 2
admitted

29-Sep-08

26-Sep-08

27-Sep-08

24-Sep-08

25-Sep-08

Case 1
admitted

Alert
issued

Date

222

CDI

Vol 33

No 2

2009

Short report

3 cases. The isolate on case 2 was serosubtyped as
B:4:P1.4. Further typing on cases 1 and 3 was not
possible as isolates were not available.

with the same serosubtype could provide evidence
for a cluster. Whether the cases were sporadic or
part of a cluster remains undetermined.

The community outbreak was declared following the
3rd case and on 20 October 2008 a public health alert
was issued to all general practitioners, emergency
departments, paediatricians and infectious diseases
specialists in the Sydney West Area Health Service.
The alert outlined the unusual increase in cases of
invasive meningococcal disease and requested that all
suspected cases be notified to the public health unit
as soon as possible following the implementation of
antibiotics and initial investigations.

The serosubtype identified from case 2 (B:4:P1.4)
is commonly identified in sporadic cases in the
eastern states of Australia with 14 cases in 2006 and
12 in 2007.9 The same serosubtype has also been
implicated in MSB outbreaks in New Zealand and
elsewhere for many years.14 It will be important to
obtain isolates for serosubtyping in all local cases
of MSB to monitor the occurrence of this strain in
New South Wales.

A follow-up epidemiological investigation was
instigated to identify common links or exposures
between the cases. The primary carer of each case
was re-interviewed on 23 October 2008 to seek
additional information to that collected at the time
the case history was taken. No direct connections
were apparent and only 2 tenuous associations
could be identified. Cases 2 and 3 had close contacts in the building and construction industry, but
no associations between these contacts could be
identified. A sibling of case 1 also attended the same
under-18 dance party on 6 October 2008 as case 3,
however the sibling had already completed a course
of clearance antibiotics at the time of the party.

Discussion
A community outbreak of MSB occurred in the
Penrith LGA of western Sydney with 10.7 cases per
100,000 population within a month. However, we
were unable to identify any common exposures or
direct links between the cases. The finding that two
of the 3 cases had close contacts in the construction industry is not surprising as this is a common
occupation in the region.12 The dance party which
occurred on 6 October 2008, after the sibling of
case 1 had received clearance antibiotics and over
a week before case 3 developed symptoms, excludes
the possibility of the sibling transmitting MSB
to case 3. However, the event provides a possible
opportunity for transmission of the meningococcus
from a contact of the sibling to case 3 and earlier to
case 1. Further exploration of this scenario was not
possible due to the unavailability of data.
In addition to failing to establish an epidemiological link between the cases, a major limitation of this
investigation was that serosubtyping of the MSB
isolates for two of the cases could not be carried out
as one could not be cultured and the other isolate
was not available for processing in the typing laboratory. In the absence of an epidemiological link, the
establishment of a biological link would assist interpretation. If the cases had different serosubtypes,
then they would be sporadic cases whereas cases
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Although the 3 cases described here were linked
in time and place, the public health investigations
highlighted the difficulty in defining a geographic
boundary for a community outbreak in a suburban
area. The 2 suburbs in question are contiguous
with other suburbs without clear natural or manmade boundaries. We chose to calculate incidence
rates based on the population of the 2 suburbs of
residence, however a lower incidence rate would
result if other geographical boundaries (such as
local government area or all adjacent suburbs) were
selected. Nevertheless, the choice of the 2 suburbs
of residence as the population denominator makes
epidemiological sense in that the 2 adjacent suburbs
had a common public bus service, and one of the
suburbs acted as a hub with a suburban shopping
centre, local library and other services, and large
sporting fields.
In addition to the challenges in identifying the presence of a community outbreak, it is difficult to determine the significance of the outbreak when MSB is
involved. Mass or risk-group-specific vaccination
programs are not possible because of a lack of a
suitable vaccine in Australia. In addition, clearance
antibiotics are not recommended for communitywide application,1 and therefore the possible public
health response is limited.
Despite the success of the MSC vaccine and subsequent reduction in numbers of cases caused by
that serotype, MSB rates have remained relatively
constant in the community over the last 10 years.
This study demonstrates that community outbreaks
of MSB as well as sporadic cases can occur, but identification of the source or location of the source of a
community outbreak of MSB can be difficult, as can
the planning and implementation of an adequate
public health response.
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